Literature DB >> 8095849

Sarcomatoid renal cell carcinoma. A study of its proliferative activity.

H Oda1, R Machinami.   

Abstract

BACKGROUND: Sarcomatoid renal cell carcinoma is an uncommon renal tumor consisting of carcinomatous and sarcomatous components. Although this tumor shows highly malignant biologic behavior, little is known about its proliferative activity.
METHODS: Twelve surgically resected sarcomatoid renal cell carcinomas were analyzed in terms of cell proliferative activity and compared with three ordinary grades of renal cell carcinomas (12, Grade 1; 12, Grade 2; and 8, Grade 3). The analysis was achieved by a silver stain for nucleolar organizer regions (AgNOR) and immunohistochemical demonstration of proliferating cell nuclear antigen (PCNA) in formaldehyde-fixed paraffin-embedded sections.
RESULTS: The mean number of AgNOR in the nucleus of renal cell carcinoma was 1.5 +/- 0.2 (mean +/- standard deviation) for Grade 1, 2.6 +/- 0.3 for Grade 2, and 5.7 +/- 1.1 for Grade 3, but 7.8 +/- 2.0 was found for sarcomatoid renal cell carcinoma. The differences in the mean number of AgNOR per nucleus among the three grades and sarcomatoid renal cell carcinoma were statistically significant (P < 0.01). PCNA labeling indexes (positive nuclear ratio) were 4.8 +/- 2.7%, 19.8 +/- 5.6%, 37.8 +/- 6.6% in Grades 1, 2, and 3, respectively, and 45.5 +/- 13.3% in sarcomatoid renal cell carcinoma. The differences in the mean number of PCNA labeling indexes between Grades 1 or 2 and sarcomatoid renal cell carcinoma were statistically significant (P < 0.005). The AgNOR count correlated well with the reactivity of tumor cells for PCNA (correlation coefficient, 0.845; P < 0.01).
CONCLUSIONS: These findings suggest that sarcomatoid renal cell carcinoma is a highly proliferative renal cell carcinoma, which may be related to its aggressive biologic behavior.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095849     DOI: 10.1002/1097-0142(19930401)71:7<2292::aid-cncr2820710720>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy.

Authors:  Brian Shuch; Jonathan Said; Jeffrey C LaRochelle; Ying Zhou; Gang Li; Tobias Klatte; Frederic Pouliot; Fairooz F Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

2.  Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.

Authors:  Mark Bi; Siming Zhao; Jonathan W Said; Maria J Merino; Adebowale J Adeniran; Zuoquan Xie; Cayce B Nawaf; Jaehyuk Choi; Arie S Belldegrun; Allan J Pantuck; Harriet M Kluger; Kaya Bilgüvar; Richard P Lifton; Brian Shuch
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-10       Impact factor: 11.205

Review 3.  Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies.

Authors:  Brian Shuch; Gennady Bratslavsky; W Marston Linehan; Ramaprasad Srinivasan
Journal:  Oncologist       Date:  2012-01-10

4.  Immunohistochemical study of C-kit expression in subtypes of renal cell carcinoma.

Authors:  Farahnaz Norouzinia; Fariba Abbasi; Sina Dindarian; Sedra Mohammadi; Farid Meisami; Mahdi Bagheri; Hozan Mohammadi
Journal:  Turk J Urol       Date:  2018-01-08

5.  p53 accumulation in colorectal cancer with hepatic metastasis.

Authors:  K Maruyama; T Tanaka; S Baba; S Nakamura; Y Endo; H Sugimura
Journal:  Jpn J Cancer Res       Date:  1996-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.